Home › Nerve Pain (Neuralgia) › NCT06029075
tACS for Neuropathic Pain Management After SCI
Recruiting
tACS Brain Neuromodulation for Sensory and Motor Recovery After Neurological Impairments
Who can join
Ages 18 to 75 · All sexes
Full eligibility criteria
Inclusion/exclusion criteria for SCI subjects Inclusion criteria: A patient who 1. has neuropathic pain after traumatic spinal cord injury or amputation or brain injury; 2. has chronic pain, \>3 months; 3. is between 18 to 75 years of age; 4. is stable on oral pain medications at least two weeks. Patients are allowed to continue their pain medications, i.e., no change in pain medications. NOTE: we plan to begin the study with the spinal cord injury (SCI) subject population as a cohort first, then expand to other subject populations Exclusion criteria: Patients will be excluded if they 1. are currently adjusting oral pain medications for their neuropathic pain; 2. have pain, but not neuropathic, e.g., from inflammation at the incision wound of the residual limb or neuroma; 3. have a pacemaker metal implants or supplemental oxygen; 4. have amputation in their arm(s); 5. fail to have a motor contraction in the arm muscles with TMS; 6. are not able to follow commands, or to give consent; 7. have asthma or other pulmonary disease; 8. are not medically stable; 9. have preexisting psychiatric disorders; 10. alcohol or drug abuse.
About the study
The overall goal is to investigate the effectiveness of a novel intervention - transcranial alternating current stimulation (tACS) for neuropathic pain management in people after spinal cord injury.
What is being tested
- tACS Sham (device)
- tACS 10Hz (device)
- tACS 20Hz (device)
Sponsor: The University of Texas Health Science Center, Houston · Participants: 14 · Started: Sep 1, 2025
Contact the study team
- Sheng Li, MD, Ph.D · Phone: (713) 797-7125
- Shengai Li, MS · Phone: 713-797-7561
Official record on ClinicalTrials.gov — NCT06029075
Locations in the U.S.
| Texas | The University of Texas Health Science Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.